Pricing Log in Create free account

Replimune Group, Inc. (REPL) vs First Tracks Biotherapeutics, Inc. (TRAX)

Replimune Group, Inc. and First Tracks Biotherapeutics, Inc. are both Biotechnology companies. Replimune Group, Inc. and First Tracks Biotherapeutics, Inc. are of similar size ($1.9B and $1.9B). Across the 8 metrics below, First Tracks Biotherapeutics, Inc. leads on 7 and Replimune Group, Inc. on 1.

Valuation

Metric REPL TRAX Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 11.16 11.31 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (12.86%) (10.82%) (32.88%)
Free cash flow yield (10.75%) (6.57%) (23.13%)

Profitability

Metric REPL TRAX Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (115.80%) 0.00% (51.96%)
Return on assets (71.01%) 0.00% (46.06%)
Return on invested capital (928.27%) 0.00% 0.00%

Growth

Metric REPL TRAX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (10.10%) — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric REPL TRAX Biotechnology median
Debt to equity 0.59 0.00 0.00
Current ratio 7.11 9.16 4.97
Net debt to EBITDA 0.51 — 1.01

Dividend

Metric REPL TRAX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric REPL TRAX Biotechnology median
Market cap 1.90b 1.91b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack